SCHEMBL2595693

SCHEMBL2595693

Cc1c(P(=S)(c2ccccc2)c2ccccc2)c2ccccc2n1C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 10/20 1.00
GPR3 P46089 1/20 0.47
KDM4E B2RXH2 5/20 0.45
ALDH1A1 P00352 2/20 0.45
GAA P10253 2/20 0.45
GLA P06280 1/20 0.45
HPGD P15428 1/20 0.45
CYP2C19 P33261 1/20 0.45
HTT P42858 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MAPT P10636 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALKBH5 Q6P6C2 1/20 0.41
FTO Q9C0B1 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
PGR P06401 1/20 0.40
NQO2 P16083 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2590788 0.81 NPSR1 (1.00) NPSR1GPR3KDM4EALDH1A1GAA
SCHEMBL29362654 0.81 NPSR1 (1.00) NPSR1GPR3KDM4EALDH1A1GAA
SCHEMBL2593679 0.79 NPSR1 (0.66) NPSR1GPR3ALDH1A1HPGDCYP2C19
SCHEMBL2587268 0.78 NPSR1 (0.63) NPSR1KDM4EALDH1A1MAPTMEN1
SCHEMBL2593998 0.78 NPSR1 (0.63) NPSR1ALDH1A1MEN1KMT2A
SCHEMBL2586743 0.75 NPSR1 (0.58) NPSR1KDM4EALDH1A1TDP1
SCHEMBL2594864 0.73 NPSR1 (1.00) NPSR1TSHR
SCHEMBL2594863 0.73 NPSR1 (1.00) NPSR1TSHR
SCHEMBL483003 0.70 GPR3 (0.61) NPSR1GPR3KDM4EALDH1A1GAA
SCHEMBL31132408 0.70 GPR3 (0.61) NPSR1GPR3KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed